TRACON Pharmaceuticals, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a TCON research report →
About the company
TRACON Pharmaceuticals, Inc. functions as a biopharmaceutical enterprise, primarily dedicated to the discovery, development, and eventual market launch of cancer treatments within the United States. Its current product pipeline features several assets in various stages of clinical trials.
- CEO
- Craig R. Jalbert CIRA
- IPO
- 2015
- Employees
- 17
- HQ
- San Diego, CA, US
Price Chart
- Market Cap
- $109.72K
- P/E
- -0.01
- P/S
- 0.01
- P/B
- -0.06
- EV/EBITDA
- 1.09
- Div Yield
- 0.00%
- Gross Margin
- 99.88%
- Op Margin
- -57.27%
- Net Margin
- -29.79%
- ROE
- 90.15%
- ROIC
- -4338.36%
- Revenue
- $12.04M · 0.00%
- Net Income
- $-3,588,000 · 87.76%
- EPS
- $-2.20 · 92.15%
- Op Income
- $-6,898,000
- FCF YoY
- 114.00%
- 52W High
- $0.75
- 52W Low
- $0.00
- 50D MA
- $0.03
- 200D MA
- $0.04
- Beta
- 1.42
- Avg Volume
- 14.43K
Get TickerSpark's AI analysis on TCON
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 7, 24 | Lazar David E. | other | 0 |
| Mar 12, 24 | Brown Scott B. | other | 224,800 |
| Apr 20, 23 | Brown Scott B. | other | 3,500 |
| Mar 12, 24 | THEUER CHARLES | other | 518,300 |
| Oct 20, 23 | THEUER CHARLES | other | 3,500 |
| Apr 20, 23 | THEUER CHARLES | other | 3,500 |
| Apr 27, 23 | THEUER CHARLES | buy | 47,000 |
| Apr 26, 23 | THEUER CHARLES | buy | 3,999 |
| Apr 19, 23 | Johnson-Pratt Lisa | other | 18,000 |
| Apr 19, 23 | Lam Carol C. | other | 18,000 |
Our TCON coverage
Recent articles, reports, and earnings notes.
No research on TCON yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate TCON report →Similar companies
Peers in the same neighborhood.